Cargando…

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course

BACKGROUND: Alzheimer's disease (AD) is frequently accompanied by sleep impairment, which can induce AD-related neurodegeneration. We herein investigated the sleep architecture, cognition, and cerebrospinal fluid (CSF) biomarkers (tau proteins and β-amyloid(42)) during AD progression from subje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liguori, Claudio, Placidi, Fabio, Izzi, Francesca, Spanetta, Matteo, Mercuri, Nicola Biagio, Di Pucchio, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942389/ https://www.ncbi.nlm.nih.gov/pubmed/31901236 http://dx.doi.org/10.1186/s13195-019-0571-3

Ejemplares similares

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity
por: Vacca, Mariacarolina, et al.
Publicado: (2023)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center
por: Vacca, Mariacarolina, et al.
Publicado: (2021)

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline
por: Liguori, Claudio, et al.
Publicado: (2017)

The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer’s Disease: A Special Focus on Cognitive Performance
por: Fernandes, Mariana, et al.
Publicado: (2021)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

(18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
por: Fernandes, Mariana, et al.
Publicado: (2022)

Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy
por: Calvello, Carmen, et al.
Publicado: (2023)

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
por: De Masi, Claudia, et al.
Publicado: (2022)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Assogna, Francesca, et al.
Publicado: (2021)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
por: Romigi, Andrea, et al.
Publicado: (2015)

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
por: Mari, Luisa, et al.
Publicado: (2021)

Sleep and wake impairment in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2020)

Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart
por: Olivola, Enrica, et al.
Publicado: (2014)

Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder
por: Mattioli, Pietro, et al.
Publicado: (2022)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014)

Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
por: Liguori, Claudio, et al.
Publicado: (2022)

Depressive and anxiety symptoms in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2021)

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2020)

Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
por: Bovenzi, Roberta, et al.
Publicado: (2023)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities
por: Mascolo, Alfredo Paolo, et al.
Publicado: (2021)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/(18)F-FDG-PET Study
por: Bonomi, Chiara Giuseppina, et al.
Publicado: (2023)

G-CSF rescues the memory impairment of animal models of Alzheimer's disease
por: Tsai, Kuen-Jer, et al.
Publicado: (2007)

Sleep quality, neurocognitive performance, and memory self-appraisal in middle-aged and older adults with memory complaints
por: Siddarth, Prabha, et al.
Publicado: (2020)

Neurocognitive Correlates of the Course of Bipolar Disorder
por: Budde, Monika, et al.
Publicado: (2014)

Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau
por: Kam, Korey, et al.
Publicado: (2019)

Neurocognitive development of memory for landmarks
por: van Ekert, Janneke, et al.
Publicado: (2015)

The Relationship of CSF and Plasma Cytokine Levels in HIV Infected Patients with Neurocognitive Impairment
por: Yuan, Lin, et al.
Publicado: (2015)

Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
por: Seo, Eun Hyun, et al.
Publicado: (2021)

Aging gene signature of memory CD8(+) T cells is associated with neurocognitive functioning in Alzheimer’s disease
por: Young, Juan Joseph, et al.
Publicado: (2023)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

Exploring Neurocognitive Deterioration in Alzheimer’s Disease
por: Franzoni, Ferdinando, et al.
Publicado: (2023)

Neurocognitive subprocesses of working memory performance
por: Lenartowicz, Agatha, et al.
Publicado: (2021)

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
por: Suárez‐Calvet, Marc, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bpn58ee4hq93stcf88tvuer6dv